skip to main content

MDS suitability for unstable medicines — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyDispensing and SupplyMDS suitability for unstable medicinesGPhC CRA

A care home asks for sodium valproate modified-release tablets to be placed into a four-week monitored dosage system. The product information warns about moisture sensitivity. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Check stability and suitability before including in the MDS

Not all medicines are suitable for monitored dosage systems due to stability, formulation or identification issues. Moisture-sensitive or modified-release products require careful assessment. Patient safety and product integrity must guide supply.

Reference: BNF; MEP